These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 21549322)

  • 1. Response to Frederic Bretzner et al. "Target populations for first-in-human embryonic stem cell research in spinal cord injury".
    Wirth E; Lebkowski JS; Lebacqz K
    Cell Stem Cell; 2011 May; 8(5):476-8. PubMed ID: 21549322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The tragedy of translation: the case of "first use" in human embryonic stem cell research.
    Solbakk JH; Zoloth L
    Cell Stem Cell; 2011 May; 8(5):479-81. PubMed ID: 21549323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Target populations for first-in-human embryonic stem cell research in spinal cord injury.
    Bretzner F; Gilbert F; Baylis F; Brownstone RM
    Cell Stem Cell; 2011 May; 8(5):468-75. PubMed ID: 21549321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Informed consent and phase 1 research in spinal cord injury.
    Stenson K; Chen D; Tansey K; Kerkhoff TR; Butt L; Gallegos AJ; Kirschner KL
    PM R; 2010 Jul; 2(7):664-70. PubMed ID: 20659722
    [No Abstract]   [Full Text] [Related]  

  • 5. Guidelines for the conduct of clinical trials for spinal cord injury as developed by the ICCP Panel: clinical trial inclusion/exclusion criteria and ethics.
    Tuszynski MH; Steeves JD; Fawcett JW; Lammertse D; Kalichman M; Rask C; Curt A; Ditunno JF; Fehlings MG; Guest JD; Ellaway PH; Kleitman N; Bartlett PF; Blight AR; Dietz V; Dobkin BH; Grossman R; Privat A;
    Spinal Cord; 2007 Mar; 45(3):222-31. PubMed ID: 17179971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical trials for the treatment of spinal cord injury: not so simple.
    Mackay-Sim A; Féron F
    Methods Mol Biol; 2013; 1059():229-37. PubMed ID: 23934846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GRNOPC1: the world's first embryonic stem cell-derived therapy. Interview with Jane Lebkowski.
    Lebkowski J
    Regen Med; 2011 Nov; 6(6 Suppl):11-3. PubMed ID: 21999256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Performance-based readability testing of participant materials for a phase I trial: TGN1412.
    Knapp P; Raynor DK; Silcock J; Parkinson B
    J Med Ethics; 2009 Sep; 35(9):573-8. PubMed ID: 19717698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systemic hypothermia for the treatment of acute cervical spinal cord injury in sports.
    Dietrich WD; Cappuccino A; Cappuccino H
    Curr Sports Med Rep; 2011; 10(1):50-4. PubMed ID: 21228652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic hypothermia for spinal cord injury.
    Dietrich WD
    Crit Care Med; 2009 Jul; 37(7 Suppl):S238-42. PubMed ID: 19535953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expectations of benefit and tolerance to risk of individuals with spinal cord injury regarding potential participation in clinical trials.
    Kwon BK; Ghag A; Dvorak MF; Tetzlaff W; Illes J
    J Neurotrauma; 2012 Dec; 29(18):2727-37. PubMed ID: 22924691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Local cooling for traumatic spinal cord injury: outcomes in 20 patients and review of the literature.
    Hansebout RR; Hansebout CR
    J Neurosurg Spine; 2014 May; 20(5):550-61. PubMed ID: 24628130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The rocky road to translation in spinal cord repair.
    Filli L; Schwab ME
    Ann Neurol; 2012 Oct; 72(4):491-501. PubMed ID: 23109144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. First patient enters trial to test safety of stem cells in spinal injury.
    Mayor S
    BMJ; 2010 Oct; 341():c5724. PubMed ID: 20940208
    [No Abstract]   [Full Text] [Related]  

  • 15. Significant clinical, neuropathological and behavioural recovery from acute spinal cord trauma by transplantation of a well-defined somatic stem cell from human umbilical cord blood.
    Schira J; Gasis M; Estrada V; Hendricks M; Schmitz C; Trapp T; Kruse F; Kögler G; Wernet P; Hartung HP; Müller HW
    Brain; 2012 Feb; 135(Pt 2):431-46. PubMed ID: 21903726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of tumorigenesis in first-in-human trials of embryonic stem cell neural derivatives: Ethics in the face of long-term uncertainty.
    Hess PG
    Account Res; 2009 Jul; 16(4):175-98. PubMed ID: 20183160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Guidelines for the conduct of clinical trials for spinal cord injury (SCI) as developed by the ICCP panel: clinical trial outcome measures.
    Steeves JD; Lammertse D; Curt A; Fawcett JW; Tuszynski MH; Ditunno JF; Ellaway PH; Fehlings MG; Guest JD; Kleitman N; Bartlett PF; Blight AR; Dietz V; Dobkin BH; Grossman R; Short D; Nakamura M; Coleman WP; Gaviria M; Privat A;
    Spinal Cord; 2007 Mar; 45(3):206-21. PubMed ID: 17179972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase 1 trial of oscillating field stimulation for complete spinal cord injury in humans.
    Tator CH
    J Neurosurg Spine; 2005 Jan; 2(1):1; discussion 1-2. PubMed ID: 15658118
    [No Abstract]   [Full Text] [Related]  

  • 19. Improvement of informed consent and the quality of consent documents.
    Jefford M; Moore R
    Lancet Oncol; 2008 May; 9(5):485-93. PubMed ID: 18452859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patient selection for clinical trials: the reliability of the early spinal cord injury examination.
    Burns AS; Lee BS; Ditunno JF; Tessler A
    J Neurotrauma; 2003 May; 20(5):477-82. PubMed ID: 12803979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.